Disruption of microfilaments by cytochalasin B decreases accumulation of cisplatin in human epidermal carcinoma and liver carcinoma cell lines

[1]  R. Gust,et al.  Dinuclear Alkylamine Platinum(II) Complexes of [1,2‐Bis(4‐fluorophenyl)ethylenediamine]platinum(II): Influence of Endocytosis and Copper and Organic Cation Transport Systems on Cellular Uptake , 2006, ChemMedChem.

[2]  M. Gottesman,et al.  Endocytic recycling compartments altered in cisplatin-resistant cancer cells. , 2006, Cancer research.

[3]  Kyung-Ryoul Kim,et al.  Direct block of cloned hKv1.5 channel by cytochalasins, actin-disrupting agents. , 2005, American journal of physiology. Cell physiology.

[4]  P. Plagemann,et al.  Membrane effects of cytochalasin B. Competitive inhibition of facilitated diffusion processes in rat hepatoma cells and other cell lines and effect on formation of functional transport sites , 1975, The Journal of Membrane Biology.

[5]  M. Sturek,et al.  Cloning, Up-Regulation, and Mitogenic Role of Porcine P2Y2 Receptor in Coronary Artery Smooth Muscle Cells , 2004, Molecular Pharmacology.

[6]  M. Gottesman,et al.  Identification of cytoskeletal [14C]carboplatin-binding proteins reveals reduced expression and disorganization of actin and filamin in cisplatin-resistant cell lines. , 2004, Molecular pharmacology.

[7]  M. Gottesman,et al.  A pleiotropic defect reducing drug accumulation in cisplatin-resistant cells. , 2004, Journal of inorganic biochemistry.

[8]  M. Gottesman,et al.  Changes in biophysical parameters of plasma membranes influence cisplatin resistance of sensitive and resistant epidermal carcinoma cells. , 2004, Experimental cell research.

[9]  T. Wieland.  Modification of actins by phallotoxins , 1977, Naturwissenschaften.

[10]  M. Gottesman,et al.  Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines. , 2003, Cancer research.

[11]  M. Gottesman,et al.  P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential. , 2003, Cancer research.

[12]  I. Koizuka,et al.  [Inhibition of caspase-9 activity in cisplatin-resistant head and neck squamous cell carcinoma]. , 2002, Nihon Jibiinkoka Gakkai kaiho.

[13]  D. Schafer,et al.  Coupling actin dynamics and membrane dynamics during endocytosis. , 2002, Current opinion in cell biology.

[14]  J. Marin,et al.  Overcoming cisplatin resistance in vitro by a free and liposome‐encapsulated bile acid derivative: BAMET‐R2 , 2000, International journal of cancer.

[15]  R. Kelly,et al.  Molecular Links between Endocytosis and the Actin Cytoskeleton , 2000, The Journal of cell biology.

[16]  I. Pastan,et al.  Decreased accumulation of [14c]carboplatin in human cisplatin‐resistant cells results from reduced energy‐dependent uptake , 2000, Journal of cellular physiology.

[17]  D. Cimini,et al.  Simultaneous inhibition of contractile ring and central spindle formation in mammalian cells treated with cytochalasin B , 1998, Chromosoma.

[18]  N. Saijo,et al.  An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells. , 1998, Experimental cell research.

[19]  I. Pastan,et al.  Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins. , 1998, Cancer research.

[20]  H. Joshi,et al.  A role for microfilaments but not microtubules in processing soluble antigens. , 1995, Cellular immunology.

[21]  I. Pastan,et al.  Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changes. , 1995, British Journal of Cancer.

[22]  R. Ozols,et al.  Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells. , 1994, Cancer research.

[23]  S. Mühlhausen,et al.  Changes in the cytoskeleton pattern of tumor cells by cisplatin in vitro. , 1992, Chemico-biological interactions.

[24]  P. Andrews,et al.  Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. , 1992, Cancer research.

[25]  M. Gottesman,et al.  Depolymerization of microtubules increases the motional freedom of molecular probes in cellular plasma membranes , 1985, The Journal of cell biology.

[26]  I. Pastan,et al.  Isolation and genetic characterization of human KB cell lines resistant to multiple drugs , 1985, Somatic cell and molecular genetics.